U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598981) titled 'PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry' on April 28.
Brief Summary: The design is an open-ended prospective observational (non-interventional) registry for subjects living with excess weight or obesity under the care of a qualified provider with documented experience treating patients with obesity
Study Start Date: Oct. 29, 2025
Study Type: OBSERVATIONAL
Condition:
Obesity
Intervention:
OTHER: Biospecimen collection
Blood Samples will be collected from subjects. This is optional for the participating subjects
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: CorEvitas
Disclaimer: Curated b...